Evidence map›Paper›PMID 38857108›Full record

ArticleCurrent protocols2024

Establishment of a Four-Cell In Vitro Blood-Brain Barrier Model With Human Primary Brain Cells.

Johid R Malik, Ukamaka O Modebelu, Courtney V Fletcher, Anthony T Podany, Kimberly K Scarsi, Siddappa N Byrareddy, Robbyn K Anand, Shilpa Buch, Susmia Sil, Jennifer Le and 4 more

Abstract read
In one paragraph

Article in Current protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. HumanBioactive materials · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Johid R MalikAntiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.
Ukamaka O ModebeluAntiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.
Courtney V FletcherAntiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.
Anthony T PodanyAntiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.
Kimberly K ScarsiAntiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.
Siddappa N ByrareddyDepartment of Pharmacology & Experimental Neurosciences, University of Nebraska Medical Center, Omaha, Nebraska.
Robbyn K AnandDepartment of Chemistry, Iowa State University, Ames, Iowa.
Shilpa BuchDepartment of Pharmacology & Experimental Neurosciences, University of Nebraska Medical Center, Omaha, Nebraska.
Susmia SilDepartment of Pharmacology & Experimental Neurosciences, University of Nebraska Medical Center, Omaha, Nebraska.
Jennifer LeUniversity of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Science, La Jolla, California.
John S BradleyUniversity of California San Diego School of Medicine, Department of Pediatrics, San Diego, California.
Ashley N BrownInstitute for Therapeutic Innovation, College of Medicine, University of Florida, Orlando, Florida.
Debapriya SutarDepartment of Pharmacology & Experimental Neurosciences, University of Nebraska Medical Center, Omaha, Nebraska.
Sean N AvedissianAntiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.ORCID https://orcid.org/0000-0002-0935-6455

Funding

Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposureU01DA058527 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley, Lishomwa C Ndhlovu · 2023 to 2026
$9.4M
Investigations of antiretroviral therapy penetration in cerebrospinal fluidK23MH125734 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI AVEDISSIAN, SEAN · 2021 to 2025
$862k
NIDA NIH HHS U01 DA058527NIH HHS K23 MH125734NIMH NIH HHS K23 MH125734
6 · The paper itself

Abstract

The blood-brain barrier (BBB) constitutes a crucial protective anatomical layer with a microenvironment that tightly controls material transit. Constructing an in vitro BBB model to replicate in vivo features requires the sequential layering of constituent cell types. Maintaining heightened integrity in the observed tight junctions during both the establishment and post-experiment phases is crucial to the success of these models. We have developed an in vitro BBB model that replicates the cellular composition and spatial orientation of in vivo BBB observed in humans. The experiment includes comprehensive procedures and steps aimed at enhancing the integration of the four-cell model. Departing from conventional in vitro BBB models, our methodology eliminates the necessity for pre-coated plates to facilitate cell adhesion, thereby improving cell visualization throughout the procedure. An in-house coating strategy and a simple yet effective approach significantly reduce costs and provides superior imaging of cells and corresponding tight junction protein expression. Also, our BBB model includes all four primary cell types that are structural parts of the human BBB. With its innovative and user-friendly features, our in-house optimized in vitro four-cell-based BBB model showcases novel methodology and provides a promising experimental platform for drug screening processes. © 2024 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Coating and culture system Basic Protocol 2: Cell seeding and Transwell insert handling Basic Protocol 3: Assessment of model functionality.

Indexed as

Blood-Brain BarrierBrainCell Culture TechniquesCells, CulturedEndothelial CellsHumansModels, BiologicalTight Junctionsblood‐brain barriercentral nervous systemhuman primary cellsin vitro model

Identifiers

PMID38857108
PMCPMC11783448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.